![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Moleculin Biotech Inc | TG:MOL | Tradegate | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.00 | - |
By Veronika Gulyas
BUDAPEST--Hungary's largest company, oil-and-gas firm MOL Nyrt. (MOL.BU) saw its unadjusted profit drop 25% in the first quarter versus a year ago, Thursday showed.
MAIN FACTS:
--MOL's first-quarter unadjusted net profit of HUF20.8 billion forints ($99 million) drop versus a net profit of HUF27.8 billion a year earlier.
-- MOL's profit drop was mainly due to lower contribution from central and eastern European gas fields, lower natural gas prices, while external conditions deteriorated in the firm's downstream segment.
--The profit drop was smaller than that expected by analysts, however, as MOL saw higher upstream production and operated in a more favorable foreign currency environment than previously expected.
--Capital expenditure, or Capex stood at HUF147 billion in 1Q. Altogether 65% of this covered acquisitions on the North Sea, while the firm spent HUF51 billion on organic projects.
-- Indebtedness ratios remained well below the comfort zone with a net gearing ratio at 18%, MOL said.
--"The first quarter of the year was made tough by the regulatory and macroeconomic environment," said Zsolt Hernadi, chief executive and chairman in the earnings report.
--MOL shares closed up 1.3% at HUF12,900 on the Budapest Stock Exchange.
Write to Veronika Gulyas at veronika.gulyas@wsj.com
Access Investor Kit for MOL Hungarian Oil & Gas Plc
Visit http://www.companyspotlight.com/partner?cp_code=A591&isin=HU0000068952
Access Investor Kit for MOL Hungarian Oil & Gas Plc
Visit http://www.companyspotlight.com/partner?cp_code=A591&isin=US6084642023
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Moleculin Biotech Chart |
1 Month Moleculin Biotech Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions